Memantine in the treatment and prophylaxis of bipolar II disorder and comorbid fibromyalgia: a case report.
J Psychiatr Pract
; 20(3): 232-6, 2014 May.
Article
en En
| MEDLINE
| ID: mdl-24847998
ABSTRACT
We have recently reported that memantine has a clinically relevant antimanic and long-lasting mood-stabilizing effect in treatment-resistant bipolar disorders, both as augmenting agent and as monotherapy. We have also observed an acute antimanic and sustained mood-stabilizing effect in a small number of patients with bipolar I disorder who had had minimal previous pharmacotherapy. In this article, we report the case of a young woman suffering from bipolar II disorder with associated fibromyalgia, in whom memantine showed an acute antimanic and a long-term prophylactic effect on both bipolar disorder as well as the associated fibromyalgia syndrome.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Trastorno Bipolar
/
Memantina
/
Fibromialgia
Límite:
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
J Psychiatr Pract
Asunto de la revista:
PSIQUIATRIA
Año:
2014
Tipo del documento:
Article